l-carnitine for cancer patients | Linus Pauling Institute Carnitine, Choline, Cancer, & Cholesterol:
Description
This was described by the original authors as "very surprising" and represented a categorically different selectivity profile from all previously characterised GHRP receptor agonists
Scientists made an unexpected discovery: standard infusion rates cause NAD+ to disappear from plasma faster during the first 2 hours
Ronger S, Touzet S, Ligeron C, et al
doi: 178/3/1809 [pii] [DOI] [PubMed] [Google Scholar] 151.Suenaert P, Maerten P, Van Assche G, Van Driessche W, Geboes K, Bulteel V, Simaels J, Augustijns P, Ceuppens JL, Rutgeerts P, Perrier C
